Eli Lilly said a late-stage trial of its new weight-loss drug showed it helped patients on high doses reduce their body weight by about a fifth raising hopes among doctors and investors that it could become a blockbuster treatment to tackle the global obesity epidemic.
禮來公司(Eli Lilly)表示，其新減肥藥的後期試驗顯示，使用高劑量減肥藥的患者減少了約五分之一的體重，這讓醫生和投資者對該藥物可能成爲解決全球肥胖問題的重磅藥物產生了希望。
您已閱讀6%（358字），剩餘94%（5267字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。